Ferric carboxymaltose versus ferric gluconate in hemodialysis patients: Reduction of erythropoietin dose in 4 years of follow-up

• প্রধান লেখক: Antonio Lacquaniti (লেখক), Patrizio Pasqualetti (লেখক), Teresa Casuscelli di Tocco (লেখক), Susanna Campo (লেখক), Stefania Rovito (লেখক), Maurizio Bucca (লেখক), Antonino Ragusa (লেখক), Paolo Monardo (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: The Korean Society of Nephrology, 2020-09-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Background : : Ferric carboxymaltose (FCM) is a parenteral, dextran-free iron formulation designed to overcome the limitations of existing iron preparations. The main aim of this study was to retrospectively examine results obtained from a long period of FCM therapy in hemodialysis patients who have...